- Home
- PERF vs TIL Comparison
PERF vs TIL Comparison
Compare PERF & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- TIL
- Stock Information
- Founded
- PERF 2015
- TIL 2018
- Country
- PERF Taiwan
- TIL United States
- Employees
- PERF N/A
- TIL N/A
- Industry
- PERF Computer Software: Prepackaged Software
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- PERF Technology
- TIL Health Care
- Exchange
- PERF Nasdaq
- TIL Nasdaq
- Market Cap
- PERF 191.5M
- TIL 171.7M
- IPO Year
- PERF N/A
- TIL 2021
- Fundamental
- Price
- PERF $1.82
- TIL $26.95
- Analyst Decision
- PERF Buy
- TIL Buy
- Analyst Count
- PERF 1
- TIL 5
- Target Price
- PERF $5.00
- TIL $119.00
- AVG Volume (30 Days)
- PERF 88.5K
- TIL 316.4K
- Earning Date
- PERF 07-23-2025
- TIL 05-13-2025
- Dividend Yield
- PERF N/A
- TIL N/A
- EPS Growth
- PERF 43.29
- TIL N/A
- EPS
- PERF 0.07
- TIL N/A
- Revenue
- PERF $61,927,000.00
- TIL N/A
- Revenue This Year
- PERF $15.93
- TIL N/A
- Revenue Next Year
- PERF $14.44
- TIL N/A
- P/E Ratio
- PERF $27.37
- TIL N/A
- Revenue Growth
- PERF 11.28
- TIL N/A
- 52 Week Low
- PERF $1.51
- TIL $9.62
- 52 Week High
- PERF $3.44
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- PERF 49.57
- TIL 65.08
- Support Level
- PERF $1.76
- TIL $12.60
- Resistance Level
- PERF $1.92
- TIL $35.28
- Average True Range (ATR)
- PERF 0.08
- TIL 3.84
- MACD
- PERF -0.00
- TIL 1.60
- Stochastic Oscillator
- PERF 33.02
- TIL 63.27
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.